Notice - Prescription Drug List (PDL): Lovastatin

Name: Notice - Prescription Drug List (PDL): Lovastatin
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to announce the revised listing for lovastatin on the Prescription Drug List (PDL). As stated in the Notice of Intent to Amend, posted June 4, 2014, the revision will allow lovastatin to be marketed as a nonprescription product. Only the Human part of the PDL has been revised.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-29

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice - Prescription Drug List (PDL): Lovastatin (English, HTML) HTML
Notice - Prescription Drug List (PDL): Lovastatin (French, HTML) HTML

Related open data

Health Canada